Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company provides FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision S, an automated scanner that develops life science research applications of single DNA molecules analysis and delivers fluorescence imaging; FiberSmart, an analysis software for replication combing assays; and accessories, which include combicoverslips, disposable DNA reservoirs, coverslips stickers, and bench holders. It offers FiberProbes; HexaCard, a genomic vision molecular combing technology offering a streamline one-stop-shop solution for biomanufacturing industries; TeloSizer, a novel tool for measurements of physical telomere length that can be applied to various model organisms; and EasyComb, EasyScan, and EasyComb Plus services. Genomic Vision Société Anonyme was founded in 2004 and is headquartered in Bagneux, France.
Frequently asked questions
What sector does Genomic Vision Société Anonyme (GV) operate in?
Genomic Vision Société Anonyme belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is Genomic Vision Société Anonyme (GV) current stock price?
As of the latest data, Genomic Vision Société Anonyme stock price is €0.00, with a previous close of €0.00.
What is Genomic Vision Société Anonyme (GV) Earnings Per Share (EPS)?
The trailing EPS is -€0.11.
Does Genomic Vision Société Anonyme (GV) pay dividends?
No. Genomic Vision Société Anonyme does not pay a dividend.
What is Genomic Vision Société Anonyme (GV) beta (volatility) score?
Genomic Vision Société Anonyme has a beta of -0.667, indicating lower volatility than the overall market.